Text Search: Search by:

Refine your search with filters

Year:

Category:

All

Congress Abstracts

Tools & Skills

Publications

Congress Presentations

Videos & Podcasts

Quicksearch

P345: The Great Continental Divide: use of anti-TNF therapy in paediatric inflammatory bowel disease is significantly different in North America compared with other parts of the world.ECCO '16 Amsterdam

Year: 2016

Authors:

P. Church¹, J. Hyams², F. Ruemmele³, L. de Ridder⁴, D. Turner⁵, A. Griffiths*¹, o.b.o. the International Paediatric IBD Network (PIBDNet)⁶

¹Hospital for Sick Children, University of Toronto, Department of Gastroenterology, Hepatology and Nutrition, Toronto, Canada, ²Connecticut Children’s Medical Centre, Hartford, United States, ³Hospital Necker Enfants Malades, Department of Paediatric Gastroenterology, Paris, France, ⁴Children’s Hospital Erasmus MC Sophia, Department of Paediatric Gastroenterology, Rotterdam, Netherlands, ⁵Shaare Zedek Medical Centre, Department of Paediatric Gastroenterology, Jerusalem, Israel, ⁶International Paediatric IBD Network (PIBDNet), Paris, France

P346: Soluble transferrin receptor and its relation to anaemia in inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

R. Dudkowiak*, K. Neubauer, E. Poniewierka

Wroclaw Medical University, Department of Gastroenterology and Hepatology, Wroclaw, Poland

P347: Identification of a cut-off for persistent anti-infliximab antibodies as a predictor of response to infliximab monotherapyECCO '16 Amsterdam

Year: 2016

Authors:

L. Del Nero*¹, G. Bodini², E. Giannini², J. Anjali³, V. Savarino¹, E. Savarino⁴

¹University of Genoa, Internal Medicine Department, Genoa, Italy, ²University of Genoa, Department of Gastroenterology and Internal Medicine, Genoa, Italy, ³Prometheus Laboratories, Department of Research and Development, San Diego, California, United States, ⁴University of Padua, Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, Padua, Italy

P348: Novel model of care: the effect of a combined inflammatory bowel disease and antenatal clinicECCO '16 Amsterdam

Year: 2016

Authors:

C. Selinger*¹, N. Carey¹, G. Ulivi², L. Walker², F. Shaik¹, T. Glanville²

¹St James University Hospital, Gastroenterology, Leeds, United Kingdom, ²St James University Hospital, Obstetrics, Leeds, United Kingdom

P349: The effects of smoking on thiopurine metabolismECCO '16 Amsterdam

Year: 2016

Authors:

B. Warner*¹, E. Johnston¹, S. Fong¹, P. Blaker¹, M. Arenas-Hernandez², A. Marinaki², J. Sanderson¹

¹Guy’s and St Thomas’ NHS Foundation Trust, Gastroenterology, London, United Kingdom, ²Guy’s and St Thomas’ NHS Foundation Trust, Purine Laboratory, Viapath, London, United Kingdom

P350: The use of concomitant immunomodulators with adalimumab therapy in paediatric Crohn’s diseaseECCO '16 Amsterdam

Year: 2016

Authors:

K. Benkov*¹, G. Russell², C. Samson³, S. Steiner⁴, E.C. King⁵, J. Pratt⁵, S. Eichner⁶, R.B. Colletti⁷, ImproveCareNow Network⁸

¹Icahn School of Medicine at Mount Sinai, Division of Pediatric Gastroenterology, New York, New York, United States, ²Boston Children’s Hospital, Harvard School of Medicine, Boston, Massachusetts, United States, ³Washington University School of Medicine, Saint Louis, Missouri, United States, ⁴Riley Hospital for Children, Pediatric Gastroenterology, Hepatology and Nutrition, Indianapolis, Indiana, United States, ⁵Cincinnati Children’s Hospital Medical Centre, Division of Biostatistics and Epidemiology, Cincinnati, Ohio, United States, ⁶AbbVie, Chicago, Illinois, United States, ⁷University of Vermont Children’s Hospital, Burlington, Vermont, United States, ⁸ImproveCareNow, Burlington, Vermont, United States

P351: Faecal calprotectin correlates well with extent of active endoscopic inflammation in patients with ulcerative colitisECCO '16 Amsterdam

Year: 2016

Authors:

D. Chayut¹, M. Kaplan², Y. Chowers³, M. Waterman*³

¹The Technion - Israel Institute of Technology, B. Rappaport Faculty of Medicine, Haifa, Israel, ²Rambam Health Care Campus, Department of Laboratory Medicine, Haifa, Israel, ³Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel

P352: Melanoma in a population-based Australian inflammatory bowel disease cohortECCO '16 Amsterdam

Year: 2016

Authors:

G. Hume*

University of Queensland, School of Medicine, Brisbane, Australia

P353: Endoscopy-based management within the first year after surgery decreases the risk of clinical and surgical postoperative recurrences in Crohn’s diseaseECCO '16 Amsterdam

Year: 2016

Authors:

A.-L. Boucher¹, B. Pereira², S. Decousus³, M. Goutte^{1, 4}, F. Goutorbe¹, A. Dubois⁵, J. Gagnière⁵, C. Borderon⁶, J. Joubert³, D. Pezet⁵, M. Dapoigny¹, P. Dechelotte³, G. Bommelaer^{1, 4}, A. Buisson*^{1, 4}

¹University Hospital Estaing, Gastroenterology Department, Clermont-Ferrand, France, ²DRCI, Biostatistics Unit, Clermont-Ferrand, France, ³University Hospital Estaing, Pathology Department, Clermont-Ferrand, France, ⁴UMR 1071 Inserm/Université d’Auvergne; USC-INRA 2018, Microbes, Intestine, Inflammation and Susceptibility of the host, Clermont-Ferrand, France, ⁵CHU Estaing, Department of Digestive surgery, Clermont-Ferrand, France, ⁶University Hospital Estaing, Paediatrics Department, Clermont-Ferrand, France

P354: A prospective randomised study: 2 mg/kg/d of azathioprine is an appropriate dosage for Chinese patients with Crohn’s diseaseECCO '16 Amsterdam

Year: 2016

Authors:

Y. Zhang*, J. Xia, Q. Cao

Sir Runrun Shaw Hospital, Zhejiang University School of Medicine, Department of Gastroenterology, Hangzhou, China

P355: Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitisECCO '16 Amsterdam

Year: 2016

Authors:

D. Seah*^{1, 2}, M. Choy^{1, 2, 3}, A. Gorelik⁴, F. Macrae⁵, M. Sparrow⁶, W.R. Connell³, G. Moore⁷, D. Van Langenberg⁸, P. De Cruz^{1, 2}

¹Austin Health, Department of Gastroenterology, Melbourne, Australia, ²University of Melbourne, Department of Medicine, Melbourne, Australia, ³St Vincent’s Hospital, Department of Gastroenterology, Melbourne, Australia, ⁴Royal Melbourne Hospital, Melbourne EpiCentre, Melbourne, Australia, ⁵Royal Melbourne Hospital, Department of Gastroenterology, Melbourne, Australia, ⁶The Alfred Hospital, Department of Gastroenterology, Melbourne, Australia, ⁷Monash Health, Department of Gastroenterology, Melbourne, Australia, ⁸Eastern Health, Department of Gastroenterology, Melbourne, Australia

P356: Efficacy and safety of certolizumab pegol in Crohn’s disease patients with loss of response or intolerance to previous anti-TNFECCO '16 Amsterdam

Year: 2016

Authors:

I. Ferrer Bradley*¹, I. Marín², N. Maroto¹, M. Mora¹, E. Hinojosa¹, B. López², L. Menchén², J. Hinojosa¹

¹Hospital de Manises, Gastroenterology, Valencia, Spain, ²Hospital Gregorio Marañón, Gastroenterology, Madrid, Spain

P357: Do you think that complementary and alternative medicine use is frequent amongst inflammatory bowel disease patients: Forget it!—results from a comparative studyECCO '16 Amsterdam

Year: 2016

Authors:

M. Rutka*¹, T. Ferenci², F. Nagy¹, Z. Szepes¹, K. Farkas¹, A. Bálint¹, R. Bor¹, A. Milassin¹, Z. Lénárt¹, T. Molnar¹

¹University of Szeged, First Department of Medicine, Szeged, Hungary, ²John von Neumann Faculty of Informatics of Óbuda University, Budapest, Hungary

P358: Six-year adalimumab efficacy in steroid-dependent Crohn’s disease patients: a prospective ‘real-life’ studyECCO '16 Amsterdam

Year: 2016

Authors:

S. Renna*¹, M. Cappello², R. Dimitri³, F. Mocciaro³, M. Mazza², M. Giunta⁴, M. Mendolaro², E. Orlando¹, M. Affronti¹, A. Craxì², M. Cottone¹, A. Orlando¹

¹”Villa Sofia-Cervello” Hospital, Division of Internal Medicine, Palermo, Italy, ²Palermo University, Department of Gastroenterology and Hepatology, Palermo, Italy, ³Arnas Civico Di Cristina Benfratelli Hospital, Gastroenterology and Endoscopy Unit, Palermo, Italy, ⁴”Villa Sofia-Cervello” Hospital, Division of Internal Medicine,, Palermo, Italy

P359: Correlation of simple laboratory tests with clinical disease activity scores in inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

O. Tayfur Yurekli, H. Koseoglu, M. Basaran, N.S. Buyukasik, a. Demirezer Bolat, F.E. Akin*, m. Tahtaci, e. Selvi, O. Ersoy

Ankara Ataturk Research and Education Hospital, Gastroenterology, Ankara, Turkey

P360: A randomised, assessor-blinded, multicentre trial comparing the efficacy, safety, and tolerability of a new tailored dosing regimen to day-before dosing regimen of colon cleansing agent used before colonoscopyECCO '16 Amsterdam

Year: 2016

Authors:

R. Kiesslich*¹, C. Angelin², K. Raymond², W. Man A Hing³, J. Masure³, M. Stoltenberg²

¹Helios Dr. Horst Schmidt Kliniken, Department of Internal Medicine II, Wiesbaden, Germany, ²Ferring Pharmaceuticals Kay Fiskers Plads 11, Copenhagen, Denmark, ³Ferring International Centre S.A, St Prex, Switzerland

P361: Adherence to faecal calprotectin test in patients with inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

C. Maréchal*¹, I. Gastin², C. Baumann², B. Dirrenberger¹, J.-L. Gueant², L. Peyrin-Biroulet¹

¹University hospital, Gastro-enterology, Vandoeuvre-les-Nancy, France, ²Inserm U954, Vandoeuvre-les-Nancy, France

P362: Anti-virus treatment against CMV in patients with ulcerative colitis by the PCR monitoring for mucosal CMV-DNAECCO '16 Amsterdam

Year: 2016

Authors:

M. Tanaka*, T. Takagi, Y. Toyokawa, Y. Hotta, K. Uchiyama, Y. Naito, Y. Itoh

Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of Molecular Gastroenterology and Hepatology, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 6028–566, Japan

P363: Efficacy and safety of golimumab in patients with ulcerative colitis: a prospective multicentre studyECCO '16 Amsterdam

Year: 2016

Authors:

D. Varvara¹, G. Costantino², A.C. Privitera³, B. Principi⁴, M. Cappello⁵, S. Mazzuoli⁶, P. Paiano⁷, A. Tursi⁸, P. Paese⁹, W. Fries¹⁰, A. Andriulli¹, F. Bossa*¹

¹IRCCS Casa Sollievo della Sofferenza, Gastroenterology, San Giovanni Rotondo, Italy, ²University of Messina, Clinical and experimental Medicine, Messina, Italy, ³Ospedale Cannizzaro, Chirurgia, Catania, Italy, ⁴University of Bari, Gastroenterology, Bari, Italy, ⁵University of Palermo, Gastroenterology, Palermo, Italy, ⁶Ospedale San Nicola Pellegrino, Gastroenterology, Trani, Italy, ⁷Ospedale di poggiardo, Gastroenterology, Poggiardo, Italy, ⁸ASL BAT, Gastroenterology, Andria, Italy, ⁹Ospedale Annunziata, Gastroenterology, Cosenza, Italy, ¹⁰University of Messina, Clinical and Experimental Medicine, Messina, Italy

P364: The efficacy of initial treatment with infliximab without previous conventional therapy in patients with moderate-to-severe ulcerative colitisECCO '16 Amsterdam

Year: 2016

Authors:

O. Prymak*

Medical Clinical Investigational Centre of the Medical Centre LLC Health Clinic, Vinnytsia, Ukraine